More
    Guided Solutions - Connecting Talent With Innovation/div>

    Lyubov Stoichkova

    357 Posts

    SoftBank’s Vision Fund backs Pear Therapeutics in $80M VC round to forge new market paths for digital treatment apps

    Pear Therapeutics, developer of prescription apps to treat addiction and insomnia, has landed $80 million through a venture capital round led by...

    UVD Robots wins EU contract to deploy 200 robots in hospitals across Europe

    UVD Robots will be Put to Work at Large Scale to Fight the Spread of Covid-19 and Reduce Hospital Acquired Infections in...

    American university receives $1.2m grant to investigate diabetes using 3D-bioprinted heart

    A university research team will assess how type 2 diabetes-related heart problems like cardiomyopathy progress in the human body

    BrainsGate raises $14M

    Ischemic stroke treatment developer BrainsGate announced today that it secured a $14 million investment to fund future regulatory efforts. Caesarea, Israel-based...

    Respiratory Health company AireHealth lands 510(k) for connected nebulizer

    The nebulizer called VitalMed is able to connect to a corresponding app designed to help patients track their symptoms.

    Omron launches home-use wheeze detection device

    Omron Healthcare has launched WheezeScan, a clinically validated automatic device for home-use to detect the presence of a wheeze in young children. 

    Sleep apnoea chin sensor diagnostic launched in the UK

    The world’s first sleep test designed to diagnose sleep apnoea and associated sleep disorders using a device that sits on your chin...

    Five breakthrough device designations granted by the FDA in November

    FDA Breakthrough Device Designations made in November included a sleep apnoea treatment to rival the CPAP machine and a neurostimulation migraine treatment

    Olympus to acquire Veran Medical Technologies for $340m

    Veran Medical provides advanced medical devices with specialisation in interventional pulmonology Olympus has agreed to acquire Veran Medical Technologies.

    MIVI enrols first patient EVAQ clinical trial for ischemic stroke

    EVAQ is a multi-centre, single-arm trial, designed to evaluate the MIVI Q Revascularisation System for neuro intervention in acute ischemic stroke patients

    Everlywell raises $175M

    Everlywell announced today that it completed an oversubscribed Series D financing round, bringing in proceeds of $175 million. Austin, Texas-based...

    Exactech acquires orthopaedic patient wearables firm Muvr

    Exactech, a medical device firm focused on orthopaedic implants, has acquired Muvr Labs, a developer of advanced wearable patientcare devices, for...

    Latest articles

    Neuromodulation treatment for chronic migraine given CE mark

    Chordate Medical Holding AB, a Swedish medtech company, has developed and patented an innovative treatment method: K.O.S. The company's existing EC-certificate for...

    Huma, which uses AI and biomarkers to monitor patients and for medical research, raises $130M

    While much of the world eagerly watches to see if the vaccination rollout helps curb and eventually stamp out Covid-19, one of...

    Endologix LLC Announces Launch of Alto Abdominal Stent Graft System in Canada and Argentina

    Endologix LLC today announced the first implant of its ALTO® Abdominal Stent Graft in Canada following recent approval from Health Canada. ALTO was...

    Bose Officially Introduces SoundControl Hearing Aids

    First FDA-Cleared Direct-to-Consumer Hearing Aid Revolutionary Bose App Clinically Proven for Audiologist-Quality Results.
    59.5k Followers
    Follow